DAM
LSTA icon

Deltec Asset Management’s Lisata Therapeutics LSTA Stock Holding History

Deltec Asset Management’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$283K Sell
83,197
-6,803
-8% -$24.2K 0.04% 213
2026
Q1 		$451K Buy
+90,000
New +$372K 0.08% 157

Other funds holding LSTA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
YCM
Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
GS
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Deltec Asset Management's LSTA Position: Q2 2026 in Review

Deltec Asset Management reduced its Lisata Therapeutics (LSTA) stake by 7.6% in Q2 2026, selling an estimated $24.2K and leaving 83,197 shares worth $283K. The position accounts for 0.04% of the portfolio, ranked #213.

Deltec Asset Management first reported a position in LSTA in Q1 2026 and has held it in 2 quarters since. The position peaked at $451K in Q1 2026. 31 funds tracked by Wall St. Rank hold LSTA as of Q2 2026.

  • Deltec Asset Management held 83,197 shares of Lisata Therapeutics worth $283K as of Q2 2026.
  • Deltec Asset Management sold 6,803 Lisata Therapeutics shares in Q2 2026, an estimated $24.2K.
  • Lisata Therapeutics made up 0.04% of Deltec Asset Management's portfolio in Q2 2026, its #213 holding.
  • Deltec Asset Management first reported a position in Lisata Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Deltec Asset Management's Lisata Therapeutics position peaked at $451K in Q1 2026.
  • 31 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q2 2026.

Based on Deltec Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.